MYC and small cell lung carcinoma: To determine whether MYC expression is associated with platinum treatment in vivo, SCLC was initiated in the RP mouse model by intranasal inoculation of adenoviral Cre-recombinase under control of a neuroendocrine promoter (Ad5-CGRP-Cre) [15, 16].